Early research (Phase 1)Study completedNCT02345707
What this trial is testing
Relative Bioavailability Study of Phase III Tablet Formulation of Cabotegravir
Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 37
Showing 20 of 0 results